Akso Health Group Sees Modest 1.65% Target Downgrade with Stable Outlook
Akso Health Group is trading at $1.78 with a target price of $1.75, reflecting a modest −1.65% downside and signaling a stable valuation outlook. Among peers, OMCC faces a −17.78% target cut, EQS shows +5.63% growth potential, and GROW has a −21.37% decrease despite positive EPS.
1. AHG Target Price Reflects Modest Downside
Akso Health Group shares trade at $1.78 versus a $1.75 target price, indicating a 1.65% potential decline. This slight adjustment underscores a stable valuation outlook for its health management services segment.
2. Divergent Peer Valuations
Old Market Capital faces a 17.78% target cut, negative EPS of 0.44 and a PE of −7.83; Equus Total Return shows a 5.63% upside despite EPS −1.10 and PE −0.80; U.S. Global Investors carries a 21.37% target decrease along with EPS of 0.07 and PE of −103.87.
Related News
AMZN
AWS Faces Challenge as Nvidia Forecasts $91B Q3 Sales, Musk Eyes 2028 Space Data Centers
AMZN•
EQNR
Equinor Sells 19% Ringvei Vest Stakes, Increases Wisting to 42.5% for $23M
EQNR•
NBTX
Nanobiotix Halts Trading to Finalize €75 M Follow-On Offering Pricing
NBTX•
CNS
Cohen & Steers Partners with J.P. Morgan on Short-Duration Hybrid Credit Fund Expansion
CNS•
SPY
SpaceX S-1 Filing Reveals $4.7B Q1 Revenue, $1.94B Operating Loss
SPY•
Sources
F